Feeling heard
Women often feel they are not being listened to when pain is their main symptom – for example, being told that heavy and painful periods are “normal” or that they will “grow out of them”.
“There can be a stigma attached to women’s health issues, which could mean that women feel uncomfortable discussing menstrual bleeding and bladder incontinence,” says Lucy Morris, patient services manager at Numark.
“This could lead to women living with abnormal symptoms that reduce their quality of life and, in some instances, could result in late cancer detection. Pharmacists who work within women’s health can reduce stigma and make their patients feel more comfortable by encouraging conversations, being culturally aware, approaching conversations sensitively and providing public awareness campaigns within the pharmacy.”
In March this year, the Royal College of Obstetricians and Gynaecologists (RCOG) said basic care is often challenging for women, who may find themselves shuttled back and forth between GP surgeries, sexual health clinics and hospitals due to the way treatments are funded and delivered. Gynaecology waiting lists have risen significantly since the pandemic began, leaving thousands of women self-managing symptoms such as heavy menstrual bleeding and pain.
“Referrals to secondary care currently need to go through a GP,” says Thorrun Govind, chair of the Royal Pharmaceutical Society in England. “So if a community pharmacist is the first port of call, they have to refer patients back to their GP to have the same conversation yet again before they can be referred to a specialist.”
Govind says that for many women’s health issues, there should be direct referral pathways from pharmacy to secondary care.
A February survey by RCOG revealed that over 60 per cent of the 2,000 UK women asked have at least one symptom of poor pelvic floor health (such as urinary incontinence or urgency) and nearly one in four have never done pelvic floor exercises, which can prevent and improve these symptoms. Most women haven’t spoken to anyone in the NHS about their pelvic floor health and over half of the women who had experienced symptoms of pelvic floor dysfunction have not sought help from a healthcare professional.
“Our research shows too few women are receiving information about pelvic floor health or the risk factors that can increase the chance of developing pelvic floor dysfunction,” says Dr Ranee Thakar, RCOG president, adding that issues like incontinence and pelvic organ prolapse are too often viewed as “normal” after childbirth.
Dr Thakar says a lack of knowledge and feelings of embarrassment often prevent women seeking help for difficult symptoms, adding that “every health professional” has a role to play in tackling stigma and helping women protect their pelvic health.
Govind agrees that community pharmacists are well placed to offer support for many women’s health problems, but says there just isn’t the funding. “Community pharmacists can help women be more confident in their own bodies,” she says, citing physiotherapy referrals as an area where pharmacies could help reduce primary care red tape for women.
Improving access
Many women report finding it difficult to access appropriate menopause care. NHS England is working with the Wellbeing of Women charity to develop an awareness-raising package among key healthcare professionals to ensure more women are advised to seek support earlier in their menopause.
“Community pharmacies now offer low dose HRT vaginal tablets to women with symptoms of the menopause without a prescription,” says Dr Thakar.
She says pharmacists should facilitate conversations with women about the different treatment options available, including lifestyle changes; HRT should not be “seen as the only treatment option”.
The new PPC for HRT came into effect in England at the beginning of April, seeking to cut the cost of prescriptions for patients receiving one or more of the eligible HRT medicines.
While this is a positive step, CPE is concerned that the certificate is launching without the IT in place to support it. PPC holders will still pay prescription charges for all other medicines. As this is a different approach from the three- or 12-month PPC, procedures and systems need to be updated as soon as possible. In addition to this, some HRT products are still subject to shortage protocols.
Dr Thakar says ongoing HRT supply issues “create barriers” to pharmacies supporting women, adding that the DHSC “must consider and build on” the recommendations made by the HRT taskforce around access.
These supply issues can add to the stress burden already faced by many menopausal women. A recent survey by Anxiety UK and Kalms found a strong association between menopause, perimenopause and anxiety symptoms, with 85 per cent of 179 surveyed women saying menopause had triggered their anxiety and 61 per cent being prescribed antidepressants as a result.
Anxiety UK CEO Nicky Lidbetter says: "Anxiety is a prevalent symptom of the menopause, but awareness amongst women and indeed healthcare practitioners is low. Societally, most of us are familiar with hot flushes and weight gain as being symptoms of the menopause; this survey however shows that we need to get much better at recognising anxiety as being a key symptom."
Heightened levels of anxiety may partly be caused by hormonal changes influencing the production of mood-regulating neurotransmitter serotonin, explains Kathy Abernethy, immediate past chair of the British Menopause Society.
